RRx-001-Induced Tumor Necrosis and Immune Cell Infiltration in an EGFR Mutation-Positive NSCLC with Resistance to EGFR Tyrosine Kinase Inhibitors: A Case Report

פריטים דומים

• RRx-001-Induced Tumor Necrosis and Immune Cell Infiltration in an EGFR Mutation-Positive NSCLC with Resistance to EGFR Tyrosine Kinase Inhibitors: A Case Report
  מאת: Christina Brzezniak, et al.
  יצא לאור: (2016-01-01)
• Partial response to carboplatin in an RRx-001 pretreated patient with EGFR-inhibitor-resistance and T790M-negative NSCLC
  מאת: Carter, Corey A., et al.
  יצא לאור: (2016)
• Partial Response to Platinum Doublets in Refractory EGFR-Positive Non-Small Cell Lung Cancer Patients after RRx-001: Evidence of Episensitization
  מאת: Carter, Corey A., et al.
  יצא לאור: (2016)
• Partial Response in an RRx-001-Primed Patient with Refractory Small-Cell Lung Cancer after a Third Introduction of Platinum Doublets
  מאת: Carter, Corey A., et al.
  יצא לאור: (2016)
• Immune Reactivity and Pseudoprogression or Tumor Flare in a Serially Biopsied Neuroendocrine Patient Treated with the Epigenetic Agent RRx-001
  מאת: Carter, Corey A., et al.
  יצא לאור: (2016)